FDA Launches AI-Powered Adverse Event System

The Food and Drug Administration on Tuesday launched the FDA Adverse Event Monitoring System (AEMS), an AI-backed platform that consolidates multiple legacy databases including FAERS and VAERS into a single real-time public portal. The agency said AEMS will process roughly 6–7 million annual reports, yielded a 3,000% pilot user increase, and is expected to save about $120 million over five years.
Key Points
- 1Launches AEMS consolidating FAERS, VAERS and other legacy systems into one AI-backed platform.
- 2Reduces data fragmentation, processes roughly 6–7 million reports annually and enables real-time publication.
- 3Improves transparency and accessibility, could save about $120 million over five years for the agency.
Scoring Rationale
Major federal deployment modernizes pharmacovigilance and promises cost savings, but reporting completeness and independent validation remain limited.
Sources
Public references used for this report.
Practice with real Ad Tech data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Ad Tech problems


